期刊文献+

EFFECTS OF RAPAMYCIN ON INTRACELLULAR CHOLESTEROL HOMEOSTASIS OF GLOMERULAR MESANGIAL CELL IN THE PRESENCE OF INTERLEUKIN-1β

EFFECTS OF RAPAMYCIN ON INTRACELLULAR CHOLESTEROL HOMEOSTASIS OF GLOMERULAR MESANGIAL CELL IN THE PRESENCE OF INTERLEUKIN-1β
下载PDF
导出
摘要 Objective To investigate the effects of rapamycin on cholesterol homeostasis of glomerular mesangial cells and the underlying mechanisms. Methods Intracellular cholesterol accumulation was measured by Oil Red O staining and high performance liquid chromatography. The effects of rapamycin on interleukin-1β(1L-1β)-induced mRNA and protein changes of low-density lipoprotein receptor (LDLR) and ATP-binding cassette transporter Al (ABCAl) were assayed by quantitative real-time PCR and Western blot. Transient expressions of 3 types of mammalian target of rapamycin (mTOR), including mTOR-WT (wild type), mTOR-RR (rapamycin resistant, with kinase activity), and mTOR-RR-KD (rapamycin resistant, without kinase activity), were obtained by plasmid transfection. Results Rapamycin had no significant influence on intracellular cholesterol concentration trader normal condition, but it significantly decreased the intracellular cholesterol concentration in the presence of IL-1β. Rapamycin dose-dependently suppressed the increased expression of LDLR induced by IL-1β and up-regulated the suppressed expression of ABCAl caused by IL-1β Transient expression of 3 types of mTOR all reduced ABCAl mRNA expression significantly, which all could be overroded by rapamycin. Conclusions Rapamycin may contribute to the maintaining of glomerular mesangial cell intracellular cholesterol homeostasis under inflammatory state by both reducing cholesterol uptake and increasing cholesterol effiux. And the effect may be not completely mediiated by mTOR.
出处 《Chinese Medical Sciences Journal》 CAS CSCD 2008年第4期205-211,共7页 中国医学科学杂志(英文版)
关键词 RAPAMYCIN glomerular mesangial cell CHOLESTEROL low-density lipoprotein receptor ATP-binding ca sette transporter A1 细胞内胆固醇 内环境稳定 脂蛋白 受体
  • 相关文献

参考文献10

  • 1Chen WX,Li PY,Wang S, et al.Measurement of serum cholesterol by high performance liquid chromatography[].Chin J Lab Med.1993
  • 2Webster,AC,Lee,VW,Chapman,JR,Craig,JC.Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials[].Transplantation.2006
  • 3Poon,M,Marx,SO,Gallo,R.Rapamycin inhibits vascular smooth muscle cell migration[].The Journal of Clinical Investigation.1996
  • 4Castro C,Campistol JM,Sancho D,et al.-independent pathway[].Atherosclerosis.2004
  • 5Pakala R,Stabile E,Jang GJ,et al.Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice:inhibitory effect on monocyte chemotaxis[].Journal of Cardiovascular Pharmacology.2005
  • 6Waksman R,Pakala R,Burnett MS,et al.Oral rapamycin inhibits growth of atherosclerotic plaque in apoE knock-out mice[].Cardiovascular Radiation Medicine.2003
  • 7MarxSO,JayaramanT,GoLO,etal.Rapamycin_FKBPinhibitscellcycleregulatorsofproliferationinvascularsmoothmusecells[].Circulation Research.1995
  • 8Elloso MM,Azrolan N,Sehgal SN,et al.Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice[].American Journal of Transplantation.2003
  • 9MoorheadJF,ChanMK,El-NahasM,etal.Lipidnephro-toxicityinchronicprogressiveglomerularandtubulo-interstitialdisease[].The Lancet.1982
  • 10Abrass,CK.Cellular lipid metabolism and the role of lipids in progressive renal disease[].American Journal of Nephrology.2004

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部